Updates from Amgen
Amgen is a worldwide pioneer in biotechnology, using living cells to make biologic medicines for patients with serious illnesses.
- AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE (Project update · November 11, 2026)
Amgen shared positive results from its Phase 3 clinical trial evaluating dazodalibep for the treatment of Sjögren's disease. The study met its primary endpoints, demonstrating the potential of the…